CONMED Corp. (CNMD) Altrus Thermal Tissue Fusion System Given Marketing Clearance by FDA

December 3, 2010 7:10 AM EST
CONMED Corporation (NASDAQ: CNMD) announced that their Altrus Thermal Tissue Fusion System has been granted marketing clearance from the U.S. Food and Drug Administration.

The company believes that the current marketplace for energy based instruments approximates $1.5 billion.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, FDA

Add Your Comment